Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.
about
The endocannabinoid system in normal and pathological brain ageingMolecular model of cannabis sensitivity in developing neuronal circuitsCannabis and psychosis/schizophrenia: human studiesBrain regional differences in CB1 receptor adaptation and regulation of transcriptionMarijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalizationThe grass isn't always greener: The effects of cannabis on embryological developmentCannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A reviewDifferential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfindingThe CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathwayAn investigation into "two hit" effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in miceDecreased reward sensitivity in rats from the Fischer344 strain compared to Wistar rats is paralleled by differences in endocannabinoid signalingNeuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents.Endocannabinoid signaling in the etiology and treatment of major depressive illness.Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum.Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling.Adenosine A2A receptor and ERK-driven impulsivity potentiates hippocampal neuroblast proliferation.In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liabilityElevation of endogenous anandamide impairs LTP, learning, and memory through CB1 receptor signaling in mice.JWH018, a common constituent of 'Spice' herbal blends, is a potent and efficacious cannabinoid CB receptor agonistThe cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia.Cannabinoid receptor activation modifies NMDA receptor mediated release of intracellular calcium: implications for endocannabinoid control of hippocampal neural plasticityExtracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects.The dual neuroprotective-neurotoxic profile of cannabinoid drugs.CB(1) cannabinoid receptors and their associated proteins.Opposite function of dopamine D1 and N-methyl-D-aspartate receptors in striatal cannabinoid-mediated signaling.Differential modulation of brainstem phosphatidylinositol 3-kinase/Akt and extracellular signal-regulated kinase 1/2 signaling underlies WIN55,212-2 centrally mediated pressor response in conscious rats.Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiationHormonal status and age differentially affect tolerance to the disruptive effects of delta-9-tetrahydrocannabinol (Δ(9)-THC) on learning in female rats.Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activationOvarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Δ⁹-THC) in adult female rats.Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development.Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling.Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors.Neuroplasticity in brain reward circuitry following a history of ethanol dependence.Dissociation of the pharmacological effects of THC by mTOR blockade.The complications of promiscuity: endocannabinoid action and metabolismMechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor.Presynaptic inhibition upon CB1 or mGlu2/3 receptor activation requires ERK/MAPK phosphorylation of Munc18-1.
P2860
Q22242668-B2E9896E-239B-4BFD-B99C-5B2694F27D6EQ24613715-5F96BA5E-E429-4067-8568-8995517F7FA6Q24628837-F2A109A0-E12D-4CAF-B936-88010E86964FQ26866100-BBFD0141-DFB3-48B3-A95D-A42C83405CD2Q27009287-89500009-5955-4773-A011-81A715D2EDC2Q28067383-FA703821-B478-4A08-8910-8E5F585ED6DCQ28257062-6C76236A-6EA8-4FDF-B9BD-14789D4DD14AQ28511922-40A4FA29-D211-4260-80A3-F728D7B416EAQ29306901-147805FE-3DA3-4ADC-89DE-4F91A76E6296Q30448071-D23B0C5C-F51A-4A09-A8CF-794563192C6BQ30470474-C3B6D277-1CBF-4C93-BA49-5BDAB77863BCQ30493991-999851F2-1F5F-4CFB-A399-F2F0B25F6A45Q30499515-D4B1CD94-41A5-4C60-BC51-CB30C74C6703Q30612936-561AB2F5-8745-47FD-869B-D8FCE391B94BQ30687668-B5E0F9E7-4DC8-4C2F-B4D8-798169A22ED4Q33199898-6F3C2982-034B-462C-893A-3BD4B7D1F423Q33620621-80BAD902-A1AE-45F6-947E-7FFBB020F1D2Q33635696-703BDBAB-34EA-4B6D-9593-96505E933BFBQ33751118-B0C8935A-1D0A-4A5E-B68C-FFDE315EDEFCQ33829479-2F174B96-83D7-4F65-BA6E-C9DA835E2BAFQ34098234-B78FF178-BF09-4569-A3AC-99CBCFA8FFA7Q34659000-3AE80874-6B6E-4DED-9AA2-F094E7FBAA8DQ34691684-9F73045C-A824-4666-AC9B-1773DACD7A5CQ35155391-F53545C4-47C1-4A3D-977A-DC4D7ECA2BE8Q35193273-0CD7F23F-76E7-4AB0-AB33-17796F80C2BBQ35232109-27738C13-AF11-4447-8460-33F337A86ACBQ35575588-ED82C50D-8CBA-46A1-A873-3B3E98B1E4C1Q35650688-193B016E-D357-44FA-AB18-146C93BE22BEQ35688747-1CDB8A96-0A42-4002-9767-B5EE5EB8B243Q35808365-3038576D-E3E2-4255-B510-FA4C4344D864Q35874442-2777BBA3-0478-4EB8-A302-DCA61E58DF06Q36109347-2300FC6B-2B77-4FA2-8480-E2B5608FD6F4Q36348362-6A166A8A-F99C-48BF-B88F-3D541135368FQ36514515-B37C5E31-8376-4A86-AD02-2DD5F63218ABQ36582466-42374F91-3A9E-4D69-BE73-0A8398C70B10Q36793931-1A824D5B-2790-4F13-840C-8C57B25B950EQ36850581-CA1F23F9-559D-49CC-B1FF-9137CBC082C2Q36944706-FA6494A4-149B-43DA-A7BE-093919B116ACQ36947742-848E5595-B51B-46F6-93FD-63DA70644319Q36954605-31DB3CE0-E6F3-44F2-8AB3-713172F4014A
P2860
Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.
@en
Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.
@nl
type
label
Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.
@en
Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.
@nl
prefLabel
Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.
@en
Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus.
@nl
P2093
P50
P1476
Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus
@en
P2093
Catherine Ledent
Hervé Enslen
James Trzaskos
Jocelyne Caboche
Madeleine Toutant
P304
P356
10.1523/JNEUROSCI.23-06-02371.2003
P407
P577
2003-03-01T00:00:00Z